Yeruusaalem, 10 Abriil, 2026 (TPS-IL) — Shirkadda Israa’iil ee sameysa daawooyinka Galmed Pharmaceuticals Ltd. ayaa ku dhawaaqday horumar muhiim ah oo ku saabsan qaab-dhismeed cusub oo daawadeeda Aramchol ah oo geli kara maskaxda, taasoo laga yaabo inay horumariso daaweynta cudurrada neerfaha sida Parkinson’s iyo waallida.
Daawooyinkan oo loo sameeyay iyadoo la kaashanayo shirkadda Barcode Nanotech oo fadhigeedu yahay Naasaret, waxay isticmaashaa nano-qaybo dufan leh si ay uga gudubto xayiraadda dhiig-maskaxeedka, taasoo ah caqabad weyn oo ku habsata daaweynta cudurrada nidaamka neerfaha dhexe. Daraasado hore oo la sameeyay ayaa muujiyay in daawadu ay yareysay isku-ururka borotiinka waxyeelada leh ee la xiriira horumarka cudurka.
Galmed waxay dooneysaa inay bilowdo tijaabooyin heerka hore ah oo lagu sameeyo dadka qaba Parkinson’s rubuci labaad ee sanadka 2026, iyadoo sugaysa tilmaamaha sharciyada.